Sanjeev Satyal - 09 Mar 2023 Form 4 Insider Report for Monterey Innovation Acquisition Corp (MTRY)

Role: Former Chief Executive Officer
Signature: /s/ Jason T. Simon, as Attorney-in-Fact
Issuer symbol: MTRY
Transactions as of: 09 Mar 2023
Net transactions value: $0
Form type: 4
Filing time: 13 Mar 2023, 20:45:02 UTC
Previous filing: 30 Sep 2021
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	MTRY	Common Stock	Other		-75,000	-50%		75,000	09 Mar 2023	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Sanjeev Satyal is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may continue.

Explanation of Responses:

Id	Content
F1	On March 9, 2023, Sanjeev Satyal resigned as Chief Executive Officer of Monterey Innovation Acquisition Corp. (the "Company") and, pursuant to an assignment dated March 9, 2023, transferred back to NorthStar Bio Ventures, LLC (the "NorthStar Co-Sponsor") 75,000 of the 150,000 shares of common stock (the "founder shares") that he received from NorthStar Co-Sponsor prior to the Company's initial public offering. The remaining 75,000 founder shares held by Mr. Satyal vested on March 9, 2023.

Content

On March 9, 2023, Sanjeev Satyal resigned as Chief Executive Officer of Monterey Innovation Acquisition Corp. (the "Company") and, pursuant to an assignment dated March 9, 2023, transferred back to NorthStar Bio Ventures, LLC (the "NorthStar Co-Sponsor") 75,000 of the 150,000 shares of common stock (the "founder shares") that he received from NorthStar Co-Sponsor prior to the Company's initial public offering. The remaining 75,000 founder shares held by Mr. Satyal vested on March 9, 2023.